Clinical trials
Expanded access COVID-19 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 14 |
| Approved for marketing | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 1 |
| Capricor Inc. | 1 |
| ContraFect | 1 |
| Gilead Sciences | 1 |
| Hackensack Meridian Health | 1 |
| Hope Biosciences Research Foundation | 1 |
| Jonathan Gerber | 1 |
| Mayo Clinic | 1 |
| Mesoblast International Sàrl | 1 |
| Nakhle Saba, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 16 |
| Coronavirus Infections | 5 |
| Severe Acute Respiratory Syndrome | 2 |
| Acute Lung Injury | 1 |
| Pneumonia | 1 |
| Pneumonia, Viral | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
| Respiratory Distress Syndrome | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.